TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: mean number of papules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: transepidermal water loss (TEWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Immediate clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease-free duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of morning sickness symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ten-year actuarial survival after diagnosis of endometrial cancer
Endpoint domain: Mortality/survival
Primary endpoint: Glucose infusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: telomerase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: flow‐mediated dilation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: C‐reactive protein concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Appointment duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concerns raised during consultations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy on spatial working memory task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Accuracy on spatial learning tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: cosmetic satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TT increase with TENS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MPT increase with 5-kHz current and TENS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HPT increase with TENS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American College of Rheumatology 20/50/70 responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: low disease activity (DAS28 ≤ 3.2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission (DAS28 < 2.6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in patient care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subscapularis muscle activation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global health-related quality of life (HRQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: knee extension range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hippocampal response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in salivary cotinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Improvement in functional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete remission of constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bowel frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interleukin‐8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: interleukin‐6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total delay time from symptom onset until CT scan completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recruitment rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: attrition rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: outcome measures completion rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Masticatory efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interval to first heroin use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay in first demand for supplemental analgesic medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morning cortisol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Heart rate after CRH administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Glucose concentrations after OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in pain related cognitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UL-FMA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cost of the procedure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: intensity of motor blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: pain scores at 45 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proven or assumed bacterial eradication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Analgesic demand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial pressure and heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: TIMI grade 3 flow in the infarct-related artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Death or reinfarction during the hospital period
Endpoint domain: Mortality/survival
Primary endpoint: Hypercalcemia measured by albumin-adjusted serum calcium
Endpoint domain: Adverse events/effects
Primary endpoint: Mean ODI value reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pfirrmann grade improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak oxygen pulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in illicit drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance in polypectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Control of upper GI bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Esophageal dilation performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of RPOC
Endpoint domain: Adverse events/effects
Primary endpoint: sperm density and motility improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Consumption of sweet items
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readmission rates within 28 days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Yo-Yo IR2 performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak blood lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rating of perceived exertion (RPE)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sensory block level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypotension and bradycardia
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of anaemia in women
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Iron deficiency (ID)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Interrater agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of hospital days per patient
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: disruptive behavior
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: pulse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness of tip and supratip skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: quantitative changes in coronary artery plaque composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean AIT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median difficulty score for catheter insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Orientation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State Regulation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: STAI score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improved knowledge and understanding of gout and its treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Involvement of patients in decision-making about treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Increased confidence about benefits from treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Crying-fussing durations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: Cost of interval appendectomy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of stereopsis threshold value perception for Titmus test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary ACR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: gall-bladder volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cumulative episodes of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Norepinephrine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence to endoscopic follow-up recommendations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: leakage of the liquefied cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: high intracapsular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: anterior capsule tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Aortic strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Aortic distensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Vegetable intake in adulthood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer assessment scores (hand + wrist)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pure Tone Average
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Word recognition scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mtDNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responses sufficient for intercourse with SIN-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged erections with P/P
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of fat oxidised
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: body fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESR and CRP levels improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgery duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: prevalence of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adverse outcome rate
Endpoint domain: Adverse events/effects
Primary endpoint: antibiotic exposure [days]
Endpoint domain: Resource use
Primary endpoint: Time to Progression (TTP) of Brain Metastases (BMs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pressure over the greater trochanter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total force during simulated sideways falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical retention rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MBF (DeltaMBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Alcohol use score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of heavy drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in chlamydia screening testing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of CanMEDS
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Acceptance of CanMEDS framework
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge of CanMEDS contents
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Sleep continuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: REM sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in HAM-A score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in the patient's 'primary need'
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: comprehensive score of symptoms of LSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: score of spinal cord function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: score of QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement of clinical signs of chronic periodontitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of IL-1beta level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: shooting performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: contrast-induced nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Viral load > or =50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IDV plasma Cmin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IDV plasma Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma HIV RNA < 200 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Injury risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: graft flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean duration for obtaining good contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Mean interval between the beginning of induction until delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Amount of necessary oxytocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Decline in LH peak amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Decrease in progesterone secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Significant decline in estradiol secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total bleeding rate (TIMI major + minor + loss-no-site)
Endpoint domain: Adverse events/effects
Primary endpoint: PI values for maternal placental and nonplacental uterine arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: PI in the fetal middle cerebral artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Apgar scores
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnosis of diabetic retinopathy (DR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: mean pain score on VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: persistence of prescription refills
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: closure times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: mean weight regain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: hemoglobin A1c decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diabetes Treatment Satisfaction Questionnaire improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: doubling serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Amount of protein extracted from lenses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of cholesterol extracted from lenses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to definitive worsening of KPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNA strand breaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of those repeating deliberate self-harm
Endpoint domain: Mortality/survival
Primary endpoint: decreased test-time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart rate at end of 40 microg/kg/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percentage of patients reaching target HR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in cannabis use
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Serum TAS levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean post-arthroscopic VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean post-arthroscopic Quick Dash score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: proportion of overall satisfied patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: proportion of weeks of satisfactory relief
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: GP consultations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: AQLQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ICIQ-SF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced serum interleukin-6 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: reduced serum interleukin-10 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: attenuated the degree of acute kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Placement in residential treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Placement changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attainment of permanency
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Reduction in total Propionibacterium acnes counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in clindamycin-resistant P. acnes counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in erythromycin-resistant P. acnes counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical activity behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time of callus formed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of severe toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of respiratory toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: working ability
Endpoint domain: Life impact
Endpoint subdomain: Role functioning